Collegium shareholders elect all eight director nominees, approve say-on-pay, ratify Deloitte

COLLEGIUM PHARMACEUTICAL, INC

All eight director nominees elected with 25.9M to 27.4M votes for each; broker non-votes 1.79M.
Advisory vote on executive compensation approved: 26.3M for, 1.1M against, 5.6K abstentions.
Ratification of Deloitte & Touche as auditor for FY 2026 passed: 28.95M for, 252.8K against.
Meeting held May 14, 2026; 29.2M of 32.4M shares present in person or by proxy.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders at the 2026-05-14 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-14

Exact text from the filing

PROPOSAL 1 : Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Approval of, on an advisory basis, the compensation of the Company's named executive officers at the 2026-05-14 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-05-14

Exact text from the filing

PROPOSAL 2: Approval of, on an advisory basis, the compensation of the Company’s named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

COLLEGIUM PHARMACEUTICAL, INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-14

Exact text from the filing

PROPOSAL 3 : Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

COLLEGIUM PHARMACEUTICAL, INC filing history →

Source: SEC EDGAR

accession 0001104659-26-062536

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.